Key result
Oxymatrine inhibited hERG current at 30°C with an IC50 of ~665 μM, but increased hERG current density at 20°C at low concentrations (≤100 μM).
Why the study?
Does oxymatrine affect hERG currents in HEK293 cells at different temperatures?
Does oxymatrine affect hERG currents in HEK293 cells at different temperatures?
Effect estimate: IC50 ~665 μM at 30°C
Oxymatrine acts as a low-potency blocker of hERG channels at 30°C but functions as a potential hERG activator at lower temperatures (20°C) at low concentrations.
Oxymatrine may alter hERG currents temperature-dependently in vitro; leaves open any clinical impact on repolarization or arrhythmia risk.
BACKGROUND/AIMS: Human ether-à-go-go-related gene (hERG) has an important role in the repolarization of the cardiac action potential. Our studies were to investigate the effects of oxymatrine (one of the natural constituents extracted from Chinese herb Sophora flavescens Ait) on hERG-encoded K(+) channels at different temperatures and its underlying mechanism. METHODS: The effects of oxymatrine were examined on hERG channels stably expressed in HEK293 cells using a whole-cell patch clamp technique. RESULTS: At the temperature 30°C, oxymatrine inhibited hERG current in a concentration-dependent manner and the IC(50) was ∼665 μM. However at the temperature of 20°C, low concentration oxymatrine C≤100 μM increased hERG current density. However, high concentration oxymatrine C>100 μM inhibited the hERG current density significantly. Oxymatrine only affected the activation kinetic of hERG channels at all temperatures and had a high binding affinity for open state of hERG channels except the 300 μM-20°C group which had a high binding affinity for inactive state of hERG channels. CONCLUSION: Oxymatrine is a low potency blocker of hERG K+ channels at 30°C, low concentration oxymatrine affect the hERG activation gating with accelerating hERG tail current at 20°C, oxymatrine is a potential hERG activator at low temperatures.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2010) studied this question. Oxymatrine was evaluated on hERG current density and activation kinetics (IC50 ~665 μM at 30°C). Oxymatrine inhibited hERG current at 30°C with an IC50 of ~665 μM, but increased hERG current density at 20°C at low concentrations (≤100 μM).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: